EMulate Therapeutics, Inc. (EMTX)

EMulate Therapeutics was planning to go public, but the IPO was withdrawn on Jul 31, 2024.

IPO Price Range

$4.00 - $6.00

Shares Offered

2,300,000

Deal Size

$11.50M

EMulate Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	69	-	-
Enterprise Value	80	-	-
Debt / Equity Ratio	-0.43	-0.20	-0.20
Debt / EBITDA Ratio	-0.43	-0.51	1.49
Debt / FCF Ratio	-2.63	-2.80	-1.76
Quick Ratio	0.01	0.01	0.00
Interest Coverage	-7.33	-6.38	2.72
Return on Equity (ROE)	117.22%	46.86%	-7.51%
Return on Assets (ROA)	-	-285.54%	16.23%
Return on Capital (ROIC)	116.59%	29.93%	38.27%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).